1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: 1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
• 英文别名: 1-(4-nitro-phenyl)-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid；1-(4-Nitro-phenyl)-2,3,4,9-tetrahydro-1H-β-carbolin-3-carbonsaeure；1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-3-carboxylate
• 化学式: C₁₈H₁₅N₃O₄
• 分子量: 337.335
• InChiKey: AALNRUIGJWDXQO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  25
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  111
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid 在 碘苯二乙酸 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 以90%的产率得到1-(4-nitrophenyl)-9H-pyrido[3,4-b]indole
  参考文献：
  名称：

  Decarboxylative Aromatization of b-Carbolines by Using Metal Free Catalysis and Efficient Synthesis of b-Carboline Derivatives

  摘要：

  合成了一种新的无金属脱羧和芳烃化的β-卡巴啉（5a-j）衍生物，采用了单锅反应法。在所有情况下，所得的β-卡巴啉衍生物的产率均超过90%。

  DOI：

  10.14233/ajchem.2015.19254
• 作为产物：
  描述：

  对硝基苯甲醛 、 DL-色氨酸 生成 1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
  参考文献：
  名称：

  β-Carboline和N -hydroxycinnamamide杂种作为抗药性肝细胞癌的抗癌药

  摘要：

  为了努力开发可以克服耐药性（导致癌症死亡的首要原因）的抗癌剂，我们开发了一系列新型的β-咔啉和N-羟基肉桂酰胺作为组蛋白脱乙酰基酶（HDAC）抑制剂。大多数杂种13a-p对四种人类癌细胞均表现出很强的抗增殖作用，且低微摩尔IC 50值。13p系列最有效的化合物显示出高HDAC1 / 6抑制作用，并且还提高了组蛋白H3，H4和α-微管蛋白的乙酰化水平。重要的是，13p对药物敏感的HepG2和Bel7402细胞以及耐药的Bel7402 / 5FU细胞表现出很高的抗癌能力。混合13p通过调节这些Bel7402 / 5FU细胞中凋亡相关蛋白的表达，触发了明显的凋亡。最后，13p通过在Bel7402 / 5FU细胞中增加LC3-II的表达以及p62和LC3-I的表达的退化而诱导了大量的自噬通量活性。总体而言，13p是一种新型的β-咔啉/ N-羟基肉桂酰胺杂化物，具有显着的抗癌效力，值得进一步评估其对耐药性肝细胞癌的治疗。

  DOI：

  10.1016/j.ejmech.2019.02.054

文献信息

• [EN] CARBOLINE AND BETACARBOLINE DERIVATIVES FOR USE AS HDAC ENZYME INHIBITORS<br/>[FR] DERIVES DE CARBOLINE ET DE BETACARBOLINE INHIBITEURS DE L'ENZYME HDAC
  申请人：CHROMA THERAPEUTICS LTD

  公开号：WO2004113336A1

  公开（公告）日：2004-12-29

  Compounds of formula (IA) and (IB) are inhibitors of histone deacetylase activity and useful for the treatment of, inter alia, cancers: wherein fused rings A1 and A2 are optionally substituted; linker radical R1 represents a radical of formula

  式（IA）和（IB）的化合物是组蛋白去乙酰化酶活性的抑制剂，用于治疗癌症等疾病：其中融合的环A1和A2可以选择性地被取代；连接基团R1代表一个公式的基团。
• Dehydrogenation of 1-aryl(hetaryl)-1,2,3,4-tetrahydro-9H-β-carboline-3-carboxylic acids and their esters with dimethyl sulfoxide
  作者：M. G. Abramyants、D. A. Lomov、T. I. Zavyazkina

  DOI：10.1134/s1070428016110117

  日期：2016.11

  boline-3-carboxylic acids derivatives with dimethyl sulfoxide leads to the formation of 1-aryl(hetaryl)-9Н-β-carbolines. Simultaneously with the dehydrogenation decarboxylation occurs. At the oxidation with dimethyl sulfoxide of methyl 1-aryl (hetaryl)-1,2,3,4-tetrahydro-9Н-β-carboline-3-carboxylicates methyl 1-aryl(hetaryl)-9Н-β-carboline-3-carboxylates formed whose hydrolysis afforded the corresponding

  1-芳基（杂芳基）-1,2,3,4-四氢-9-氧化脱氢Н -β-β-咔啉-3-羧酸的衍生物与二甲亚砜通向1-芳基（杂芳基）-9形成Н - β-咔啉。与脱氢同时发生脱羧。在用甲基1-芳的二甲亚砜（杂芳基）-1,2,3,4-四氢-9-氧化Н -β-β-咔啉-3- carboxylicates甲基-1-芳基（杂芳基）-9- Н -β咔啉形成3-羧酸盐，其水解得到相应的1-芳基（杂芳基）-9Н -β-咔啉-3-羧酸。
• Kinesin inhibitors
  申请人：Feng Yan

  公开号：US20050004156A1

  公开（公告）日：2005-01-06

  The present invention provides for compounds, compositions, methods and systems for inhibiting cell growth. More specifically, the present invention provides for methods, compounds and compositions which are capable of inhibiting mitosis in metabolically active cells. Compounds, compositions and methods of the present invention inhibit the activity of a protein involved in the assembly and maintenance of the mitotic spindle. One class of proteins which acts on the mitotic spindle is the family of mitotic kinesins, a subset of the kinesin superfamily.

  本发明提供了用于抑制细胞生长的化合物、组合物、方法和系统。更具体地，本发明提供了一种能够抑制代谢活跃细胞中有丝分裂的方法、化合物和组合物。本发明的化合物、组合物和方法抑制了参与有丝分裂纺锤体组装和维持的蛋白质的活性。作用于有丝分裂纺锤体的蛋白质类别之一是有丝分裂动力蛋白家族中的一类蛋白质，这是有丝分裂动力蛋白超家族的一个子集。
• β-Carbolines as specific inhibitors of cyclin-Dependent kinases
  作者：Yongcheng Song、Jian Wang、Su Fern Teng、Djohan Kesuma、Yu Deng、Jinao Duan、Jerry H. Wang、Robert Zhong Qi、Mui Mui Sim

  DOI：10.1016/s0960-894x(02)00094-x

  日期：2002.4

  Harmine (3), 7-fluoro-1-methyl beta-carboline (35) and 1-(5-methyl-imidazol-4-yl) beta-carboline (41) were potent and specific inhibitors of cyclin-dependent kinases. The degree of aromaticity of the tricyclic ring and the positioning of substituents are important for inhibitory activity. While most beta-carbolines inhibited CDK2 and CDK5 to the same extent. selective inhibition against CDK2 was observed in 1-(2-chlorophenyl)- (12), 1-(2-fluorophenyl)- (15), and 1-(2-chloro-5-nitrophenyl)- (28) beta-carbolines. (C) 2002 Elsevier Science Ltd. All rights reserved.
• Synthesis and anti-leishmanial activity of 1-aryl-β-carboline derivatives against Leishmania donovani
  作者：Vikrantsinh M. Gohil、Keyur G. Brahmbhatt、Philippe M. Loiseau、Kamlesh K. Bhutani

  DOI：10.1016/j.bmcl.2012.04.115

  日期：2012.6

  beta-carbolines from various natural and synthetic sources have been known to show diverse biological activities. As a part of our current ongoing project to search for potent natural product-derived anti-leishmanial compounds, we have synthesized a series of substituted 1-aryl-beta-carboline derivatives. A total of 22 compounds were synthesized and tested in vitro against Leishmania donovani, out of which 6 compounds (4, 5, 10, 11, 19 and 22) showed notably more activity than the standard miltefosine (IC50 12.07 +/- 0.82 mu M), with compound 4 being the most potent (IC50 2.16 +/- 0.26 mu M). (C) 2012 Elsevier Ltd. All rights reserved.